Skin Cancer | Tumor

CURE’s skin cancer page is an extensive resource of cancer information featuring the latest skin cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on skin cancer.

Treatment Challenges in Advanced Lung Cancer

November 13th 2017

Side Effect Management in Advanced Lung Cancer

November 13th 2017

Promising Cancer Therapies in Advanced Lung Cancer

November 13th 2017

Palliative Care in Advanced Lung Cancer

November 13th 2017

Missing Mom

November 13th 2017

Two-time cancer survivor struggles with a different loss than cancer this holiday season.

Don't Let Cancer Ransom the Joy of the Holiday Season

November 11th 2017

Are you trying to get ready for the holidays in addition to being newly diagnosed with cancer, receiving active treatment or coping with survivorship? It’s not an easy task.

10 Diet and Exercise Tips for People Who Say, 'I Can't'

November 10th 2017

A two-time cancer survivor shares strategies that have helped her over the years with healthy eating habits and movement.

Combination Continues to Show Impressive Outcomes in Melanoma

November 3rd 2017

In an interview with CURE, Postow, a medical oncologist specializing in melanoma at Memorial Sloan Kettering Cancer Center, discussed the impressive efficacy seen with combining BRAF and MEK inhibitors for patients with melanoma.

Despite Laws Limiting Minors, Indoor Tanning Salons Not 100 Compliant

November 2nd 2017

Nearly a third of tanning salons surveyed were not compliant with their state laws.

Solving a Mystery to Fight a Rare Cancer

October 25th 2017

An immunotherapy finally gives doctors an approved weapon to fight Merkel cell carcinoma, a rare and still mysterious skin cancer.

New Normal: Life Before And After Cancer

October 24th 2017

It isn't always so "normal," is it?

Drug Combination Granted FDA Breakthrough Designation for Melanoma Treatment

October 23rd 2017

The combination of Tafinlar (dabrafenib) and Mekinist (trametinib) was granted a breakthrough therapy designation by the Food and Drug Administration (FDA) for the adjuvant treatment of patients who have stage 3 melanoma and a BRAF V600 mutation, after they have already had a complete resection.

Novel Therapy Combinations Are Needed for Melanoma Treatment

October 23rd 2017

Research into combination approaches now focuses on using three anti–PD-1 therapies and new checkpoints, such as IDO.

Immunotherapy Combination Sparks a Response in Melanoma Brain Metastases

October 23rd 2017

The combination of the immunotherapies Opdivo (nivolumab) and Yervoy (ipilimumab) sparked a response in nearly half of asymptomatic patients with melanoma brain metastases who had not received prior local therapy to the brain.

New Immunotherapy Shows Response for Metastatic Melanoma, Study Says

October 23rd 2017

The longest response rate lasted six months.

Immunotherapy Offers New Optimism for Patients With Merkel Cell Carcinoma

October 20th 2017

Although chemotherapy has been used to treat patients with Merkel cell carcinoma, immunotherapy agents show great promise, according to findings presented at the 2017 World Congress of Melanoma.

Associating Genes With Melanoma Risk

October 19th 2017

Maria T. Landi, M.D., Ph.D., principal investigator at the National Cancer Institute (NCI) and National Institutes of Health (NIH) discusses a recent study that identified genetic variations that may be linked with increased melanoma risk.

Intralesional Combinations Are Promising in Melanoma

October 19th 2017

Intralesional therapies – those delivered directly to the tumor site – used in conjunction with checkpoint inhibitors have shown improvements to the treatment of people with melanoma, says Robert Andtbacka, M.D., in a presentation at the 2017 World Congress of Melanoma.

Care to Comment on Draft USPSTF Statement on Sun Protection?

October 19th 2017

Members of the public can submit comments to the U.S. Preventive Services Task Force (USPSTF) on its draft recommendation statement on sun protection until Nov. 6, 2017.

Opdivo Granted Priority Review for Post-Surgical Melanoma Treatment

October 18th 2017

Opdivo (nivolumab) was granted a priority review to a supplemental biologics license application (sBLA) to treat patients with melanoma who have a high risk of disease recurrence after complete surgical resection, according to Bristol-Myers Squibb (BMS), the company that makes the drug.

Stubbornness Will Get You Through Cancer

October 12th 2017

Seven-year cancer survivor shares tips to help you get through cancer.

Challenges Remain in Melanoma Treatment, Expert Says

October 8th 2017

Merrick I. Ross, M.D., discussed key issues in melanoma as the treatment paradigm continues to change.

Moving Forward Through Fear of Recurrence

October 5th 2017

Breast cancer survivor shares how she copes with fear of recurrence while coping with her mom's breast cancer death and other life changes.

Pen-Like Device May Help Detect Melanoma

October 5th 2017

Patients and providers can evaluate lesions within seconds by running the tip of the device over their skin, and then link the results to a user-friendly smartphone app.

Drug Pair Benefits Patients With Melanoma Who Progressed on Prior Therapy

October 3rd 2017

Combination therapy of Opdivo (nivolumab) and LAG-3 inhibitor relatlimab (BMS-986016) benefitted half of the patients with melanoma who previously progressed on an anti-PD-1 or anti-PD-L1 therapy, according to recent results from a dose-expansion study.

When to Stop Immunotherapy Treatment for Melanoma

October 2nd 2017

Yania Jansen, surgical trainee at Vrije Universiteit Brussel, in Brussels, Belgium, discusses the possibility of stopping treatment with Keytruda (pembrolizumab) for patients with melanoma.

Would Recent Advancements Make You Revisit Cancer?

September 27th 2017

Would you go see a genetics counselor again, now that there may be more to test for? Would you get a double mastectomy seven years out?

5 Health Care Wishes from a Cancer Survivor

September 25th 2017

Breast cancer survivor reflects back on what she wishes the medical profession's approach could have been to her cancers.

On Cancer and Facing Death Bravely

September 22nd 2017

Two-time cancer survivor says lets look death and dying in the face so we don't live our lives in (as much) fear.

White Blood Cell Ratios Predict Melanoma Patients' Survival

September 21st 2017

The ratio of neutrophils to lymphocytes – two types of white blood cells – can give oncologists valuable information regarding a patient’s prognosis.